Anthropic's Mythos Preview was highly effective at finding vulnerability candidates, especially when analyzing source code.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Private equity investor Arcus Infrastructure Partners has bought a majority stake in regional aircraft lessor TrueNoord, its only current investment in the aviation sector. Arcus agreed to buy a 74% ...

Arcus Biosciences (RCUS) traded lower in the premarket on Monday after the oncology-focused biotech announced the discontinuation of a late-stage trial designed to evaluate its anti-TIGIT therapy ...

Arcus Biosciences is discontinuing a phase 3 lung cancer trial it was conducting with Gilead Sciences. Arcus, an oncology company, said Monday it was ending the trial due to futility, meaning it doesn ...

Add Outdoor Life (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. A ...

Add Yahoo as a preferred source to see more of our stories on Google. The short video clip shows the Burmese python regurgitating the bird whole in a matter of seconds. A professional python hunter in ...

Arcus Biosciences posted strong FY25 results, beating EPS and revenue estimates despite no commercial products and heavy R&D investment. RCUS’s valuation premium is driven by Casdatifan, a ...

Arcus Infrastructure Partners will acquire Wifinity, a UK-based internet managed services provider, from LDC and Literacy Capital. Literacy will generate a total expected return of 5.2x MoM, in line ...

Dec 12 (Reuters) - Arcus Biosciences (RCUS.N), opens new tab said on Friday it would stop a late-stage study testing its experimental cancer drug combination in patients with advanced stomach and ...

Arcus Biosciences will now focus on cancer drug casdatifan as well as earlier work outside of oncology. (iStock / Getty Images Plus) A key late-stage trial of Arcus Biosciences and Gilead Sciences' ...